Flavonoids, Chalcones, and Their Fluorinated Derivatives—Recent Advances in Synthesis and Potential Medical Applications
Molecules · 30.05.2025 · 30 (11) · 2395
DOI: 10.3390/molecules30112395 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 30.05.2025. Verfasst von Jakub Kubiak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Chalcones, Flavonoids. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Center, Poland.
Abstract (Originalsprache)
Flavonoids and chalcones, widely recognised for their diverse biological activities, have garnered attention due to their potential therapeutic applications. This review discusses fluorinated flavonoids and chalcones, focusing on their prospective anti-inflammatory, antidiabetic, anticancer, antiosteoporotic, cardioprotective, neuroprotective, hepatoprotective, antimicrobial, and antiparasitic applications. The enhanced biological activities of fluorinated derivatives, particularly the antibacterial, antiviral, and anticancer properties, are attributed to the introduction of fluorine groups, which increase lipophilicity and metabolic stability. Key findings indicate that fluorinated flavonoids and chalcones exhibit synergistic effects with antibiotics, inhibit bacterial efflux pumps, and reveal potent antiviral and anticancer properties. However, challenges such as cytotoxicity and structural optimisation have to be addressed. The synthesis of fluorinated flavonoids and chalcones is discussed, with emphasis on various synthetic methods such as condensation and cyclisation reactions starting from fluorinated precursors, as well as fluorination strategies, including the use of molecular fluorine or fluorinating agents. Fluorinated flavonoids and chalcones represent candidates for therapeutic development and have the potential to overcome drug resistance. However, further studies are necessary to adjust their pharmacological profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.
- Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
ORCID-Profile: Jakub Kubiak, Beata Czarczynska-Goslinska, Tomasz Goslinski
Förderung
- National Science Center
- National Science Center, Poland
Zitieren
APA
Kubiak, J., Szyk, P., Czarczynska-Goslinska, B., & Goslinski, T. (2025). Flavonoids, Chalcones, and Their Fluorinated Derivatives—Recent Advances in Synthesis and Potential Medical Applications. Molecules, 30(11), 2395. https://doi.org/10.3390/molecules30112395
Vancouver
Kubiak J, Szyk P, Czarczynska-Goslinska B, Goslinski T. Flavonoids, Chalcones, and Their Fluorinated Derivatives—Recent Advances in Synthesis and Potential Medical Applications. Molecules. 2025;30(11):2395. doi:10.3390/molecules30112395
BibTeX
@article{Kubiak2025,
author = {Kubiak, Jakub and Szyk, Piotr and Czarczynska-Goslinska, Beata and Goslinski, Tomasz},
title = {Flavonoids, Chalcones, and Their Fluorinated Derivatives—Recent Advances in Synthesis and Potential Medical Applications},
journal = {Molecules},
year = {2025},
volume = {30},
number = {11},
pages = {2395},
doi = {10.3390/molecules30112395}
}
EUVIMED